Mark Pollack to Lipopolysaccharides
This is a "connection" page, showing publications Mark Pollack has written about Lipopolysaccharides.
Connection Strength
0.311
-
Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect Immun. 1994 Apr; 62(4):1137-43.
Score: 0.110
-
Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis. 1989 Feb; 159(2):168-88.
Score: 0.077
-
Monoclonal antibodies that recognize epitopes in the core and lipid A region of lipopolysaccharides. Prog Clin Biol Res. 1988; 272:327-38.
Score: 0.071
-
Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Invest Ophthalmol Vis Sci. 1997 Jun; 38(7):1418-25.
Score: 0.034
-
Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis. 1989 May; 159(5):872-80.
Score: 0.020